ACCC Precision Medicine: Transforming Complex to Clear



In This Section

Home / Learn / Precision Medicine

Precision Medicine

Precision medicine (also known as personalized medicine) uses information about a person’s genes, proteins, and environment to prevent, diagnose, and treat cancer. Precision medicine includes the use of biomarkers, molecular testing, and targeted therapies to deliver a personalized approach to cancer therapy through the use of molecular and genomic information about individual cancers. The National Cancer Institute (NCI) defines precision medicine as “discovering unique therapies that treat an individual’s cancer based on the specific abnormalities of their tumor.”

Transforming Complex to Clear

ACCC develops comprehensive Precision Medicine resources that bring clarity to complex patient care decisions. Designed for multidisciplinary cancer teams, the resources enable clinicians to make educated and holistic decisions that can positively influence patient outcomes. No matter your learning style—podcasts, on-demand webinars, videos, or publications—the ACCC Precision Medicine Library has resources that provide essential knowledge you can apply to your patient care.

On-Demand Webinars

Cancer Buzz Podcast

  • [MINI-PODCAST] Ep 82: Liquid Biopsy: Cancer Detection & Future Synergies
    Apr 19, 2022

    Stephen Quake, PhD, spoke to CANCER BUZZ about the application of liquid biopsies across multiple cancer stages and their potential to improve patient outcomes, minimize financial toxicity, and create health equity through greater testing access and lower cost.

  • [PODCAST] Ep 80: The Promise of MRD Testing in Multiple Myeloma & CLL
    Mar 29, 2022

    While not yet mainstream in the community setting, hear how measurable residual disease (MRD) testing has the potential to become more fully integrated into clinical practice as one of the reliable markers of treatment response for patients with multiple myeloma and chronic lymphocytic leukemia.  

  • [PODCAST] Ep 76: Improving Pathology Reports
    Feb 7, 2022

    Simplifying and standardizing pathology reports so patients are better informed, understand their prognosis, and own the progress of their therapies is of critical importance in today's episode. 

  • [PODCAST] Ep 75: Developments in TIL Cell Therapy
    Jan 25, 2022

    In this episode, hear from two experts in cancer immunotherapy on the exciting potential of TIL Cell Therapy in melanoma and beyond.

  • [PODCAST] Ep 73: Biomarker Testing Advocacy
    Dec 7, 2021

    Biomarker testing is crucial to precision medicine, but barriers still exist. Learn from two healthcare advocates about recent policy changes designed to ensure better access to biomarker testing.

  • [MINI-PODCAST] Ep 72: Genetic Counseling Advocacy
    Nov 30, 2021

    Hear from Colleen Campbell, PhD, MS, LGC, as she explains policy changes that can help patients access genetic counseling services, while also benefiting those who provide these services. 

  • [VIDEO PODCAST] Ep 09: Precision Medicine Disparities
    Nov 11, 2021

    Hear from two authors of an ACCC/LUNGevity Foundation study that identified key areas of clinician need related to biomarker testing in NSCLC. 

  • [VIDEO PODCAST] Ep 07: Genetic Testing & Telehealth
    Oct 21, 2021

    Genetic counselors—as members of the cancer care team—can help patients better understand their cancer diagnosis, make informed treatment decisions, and navigate the financial costs of testing.

  • [PODCAST] Ep 55: What You Need to Know about Liquid Biopsy
    Mar 30, 2021

    Learn about the current clinical applications of liquid biopsies, associated reimbursement issues, and what you can do to implement these tests at your program.

  • [PODCAST] Ep 53: Telehealth & Genetics During COVID-19
    Feb 23, 2021

    Learn how genetic healthcare services have adapted to virtual care delivery, and what challenges face its widespread use after the COVID-19 pandemic is over.


  • MM-Awareness-Month-240x160
    Expanding Awareness of Multiple Myeloma
    March 23, 2022
    March is Multiple Myeloma Awareness Month. Learn how ACCC is supporting collaboration among healthcare providers with practical, scalable solutions to the real-world challenges of improving quality care delivery for patients with multiple myeloma.
  • Cell-culture-test-in-laboratory-768x512
    Must-Listen Podcasts on Precision Medicine
    December 13, 2021
    While precision medicine in cancer care is becoming more widespread, its rapid evolution in oncology requires ongoing discussion. ACCC’s podcast, CANCER BUZZ, features lively expert discussions about emergent issues in cancer care. Here we highlight some of those podcasts.
  • Precision Medicine 300x200
    Transforming Complex to Clear: New Precision Medicine Tools
    November 09, 2021
    ACCC has launched Transforming Complex to Clear—a precision medicine campaign that has developed a range of tools and resources to help bring clarity to complex patient care decisions. Designed for multidisciplinary cancer teams, learn more about how these resources can enable clinicians to make educated and confident decisions.
  • Biomarker Testing NSLC Roadmap
    ACCC Launches Precision Medicine Campaign
    November 04, 2021
    In launching its new campaign, "Transforming Complex To Clear," ACCC brought together expert panelists to discuss effective practices and offer tips to address current barriers to biomarker testing in the community setting.
  • barriers-to-liquid-biopsy-240x160
    Barriers to Liquid Biopsy
    October 14, 2021
    Liquid biopsy, a genetic test that can eliminate some of the most serious potential drawbacks of traditional tissue biopsy, is gaining more traction in cancer care. But there remain significant barriers to its widespread use.
  • lung-cancer-screening-400x267
    ACCC Recognizes World Lung Cancer Day
    July 29, 2021
    August 1 marks World Lung Cancer Day. Long at the forefront of teaching multidisciplinary cancer care teams about how to best implement new and evolving lung cancer therapies into their programs and practices, ACCC shares several of its current initiatives to promote optimal lung cancer care delivery.
  • Blocks arranged to spell out policy
    ACCC Signs Statement on Medicare MCED Screening Coverage Act of 2021
    March 22, 2021
    Led by the Prevent Cancer Foundation, ACCC has joined more than 300 organizations in signing a letter urging the passage of the MCED Screening Coverage Act, which will help cancer care providers be able to use the latest testing technologies to improve quality of life and better patient outcomes.

From Oncology Issues

Digital tools

Biomarker Lexicon
Explore the many terms associated with the different areas and applications of cancer biomarkers.

Biomarker Resource Library
Search this resource bank of nationally available materials relevant to cancer biomarkers and biomarker testing. You may filter by cancer type, area of application, and/or primary audience.

Biomarker Toolkit
This practical toolkit is centered around the four key elements needed to develop a precision medicine program that successfully incorporates biomarker testing.

MRD Testing Implementation Roadmap
Navigate how to lay the groundwork for MRD testing, prepare your care team, implement testing, and evaluate ongoing progress.

MRD Testing Resource Library
Curated materials to help establish and implement MRD testing for your patients with adult B-cell ALL.

Biomarker Testing Implementation Roadmap for Advanced NSCLC
An innovative tool to implement, expand, and sustain biomarker testing for patients with advanced NSCLC.

Biomarker Testing Resource Library
Curated materials to support the implementation of biomarker testing for patients with advanced NSCLC.

Bispecific Antibodies Resources
Links to recent scholarship and resources that can help practices better serve their patients who may be eligible for TRBA therapy.

Abstracts & Presentations

News & Media